Sesquiterpene glucosides from anti-leukotriene B4 release fraction of Taraxacum officinale

被引:22
|
作者
Kashiwada, Y
Takanaka, K
Tsukada, H
Miwa, Y
Taga, T
Tanaka, S
Ikeshiro, Y [1 ]
机构
[1] Niigata Coll Pharm, Kamishinei Cho, Niigata 9502081, Japan
[2] Kyoto Univ, Grad Sch Pharmaceut Sci, Sakyo Ku, Yoshida, Kyoto 6068304, Japan
[3] Tokyo Univ Agr, Fac Appl Biosci, Setagaya Ku, Sakuragoaka, Tokyo 1568502, Japan
关键词
Taraxacum officinale; Compositae; anti-leukotriene B-4 formation; germacrane; sesquiterpene;
D O I
10.1080/10286020108041390
中图分类号
Q94 [植物学];
学科分类号
071001 ;
摘要
Chemical examination of the MeOH extract of the root of Taraxacum officinale, which exhibited inhibitory activity on the formation of leukotriene Bq from activated human neutrophils, has resulted in the isolation of 14-O-beta -D-glucosyl-11,13-dihydro-taraxinic acid (1) and 14-O-beta -D-glucosyl-taraxinic acid (2). The absolute stereostructure of 1 has been established by X-ray chrystallographic examination.
引用
收藏
页码:191 / 197
页数:7
相关论文
共 50 条
  • [21] Assessment of leukotriene B4 production in leukocytes from horses with recurrent airway obstruction
    Lindberg, Å
    Robinson, E
    Näsman-Glaser, B
    Jensen-Waern, M
    Lindgren, JÅ
    AMERICAN JOURNAL OF VETERINARY RESEARCH, 2004, 65 (03) : 289 - 295
  • [22] Pro- and anti-inflammatory mediators change leukotriene B4 and leukotriene C4 synthesis and secretion in an inflamed porcine endometrium
    Czarzasta, J.
    Andronowska, A.
    Jana, B.
    DOMESTIC ANIMAL ENDOCRINOLOGY, 2014, 49 : 49 - 59
  • [23] Elevated levels of leukotriene B4 and leukotriene E4 in bronchoalveolar lavage fluid from patients with scleroderma lung disease
    Kowal-Bielecka, O
    Distler, O
    Kowal, K
    Siergiejko, Z
    Chwiecko, J
    Sulik, A
    Gay, RE
    Lukaszyk, AB
    Gay, S
    Sierakowski, S
    ARTHRITIS AND RHEUMATISM, 2003, 48 (06): : 1639 - 1646
  • [24] Chitin and chitosan stimulate canine polymorphonuclear cells to release leukotriene B4 and prostaglandin E2
    Usami, Y
    Okamoto, Y
    Takayama, T
    Shigemasa, Y
    Minami, S
    JOURNAL OF BIOMEDICAL MATERIALS RESEARCH, 1998, 42 (04): : 517 - 522
  • [25] Release of Leukotriene B4, Transforming Growth Factor-β1 and Microparticles in Relation to Aortic Valve Calcification
    Kochtebane, Najlah
    Passefort, Stephanie
    Choqueux, Christine
    Ainoun, Fadela
    Achour, Lotfi
    Michel, Jean-Baptiste
    Baeck, Magnus
    Jacob, Marie-Paule
    JOURNAL OF HEART VALVE DISEASE, 2013, 22 (06): : 782 - 788
  • [26] Corticosteroid suppression of lipoxin A4 and leukotriene B4 from alveolar macrophages in severe asthma
    Bhavsar, Pankaj K.
    Levy, Bruce D.
    Hew, Mark J.
    Pfeffer, Michael A.
    Kazani, Shamsah
    Israel, Elliot
    Chung, Kian Fan
    RESPIRATORY RESEARCH, 2010, 11
  • [27] Human melanoma cells generate leukotrienes B4 and C4 from leukotriene A4
    Hiroko Okano-Mitani
    K. Ikai
    Sadao Imamura
    Archives of Dermatological Research, 1997, 289 : 347 - 351
  • [28] Inhibition of plasma oxidation and reduction of leukotriene B4 release after oral administration of AGI-1067, a novel anti-atherosclerotic agent
    Kunsch, C.
    Qiu, F-H.
    Suen, K-L.
    Shao, N.
    Simmons, L. K.
    ATHEROSCLEROSIS SUPPLEMENTS, 2007, 8 (01) : 185 - 186
  • [29] POLYMORPHONUCLEAR (PMN) CELL INFILTRATION AND LEUKOTRIENE B4 (LTB4) RELEASE IN EXPERIMENTAL SPINAL-CORD INJURY
    XU, J
    LIU, TH
    HOGAN, EL
    PEROT, PL
    HSU, CY
    FASEB JOURNAL, 1988, 2 (04): : A409 - A409
  • [30] RELEASE OF LEUKOTRIENE-B4 FROM RAT KUPFFER CELLS
    SAKAGAMI, Y
    MIZOGUCHI, Y
    SEKI, S
    KOBAYASHI, K
    MORISAWA, S
    YAMAMOTO, S
    PROSTAGLANDINS LEUKOTRIENES AND ESSENTIAL FATTY ACIDS, 1989, 36 (03): : 125 - 128